ResearcherNo recent work listed

Xiaoran Qin

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5020324946. Sources: OpenAlex.

Their work

Papers: 3
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 3

Papers, trials and grants by year

2012: 3 papers

Papers 3

Transactivation of the human NME5 gene by Sp1 in pancreatic cancer cells. Co-author DOI 10.1016/j.gene.2012.04.088 ↗
Identification of NME5 as a contributor to innate resistance to gemcitabine in pancreatic cancer cells. Co-author DOI 10.1111/j.1742-4658.2012.08521.x ↗
Intrinsic gemcitabine resistance in a novel pancreatic cancer cell line is associated with cancer stem cell-like phenotype. Co-author DOI 10.3892/ijo.2011.1254 ↗

Closest collaborators

The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Fu Li · 2 shared papers, 2012 · strength 0.06
- Paper Identification of NME5 as a contributor to innate resistance to gemcitabine in pancreatic cancer cells. DOI 10.1111/j.1742-4658.2012.08521.x ↗
- Paper Transactivation of the human NME5 gene by Sp1 in pancreatic cancer cells. DOI 10.1016/j.gene.2012.04.088 ↗
Luyong Zhang · 2 shared papers, 2012 · strength 0.06
- Paper Identification of NME5 as a contributor to innate resistance to gemcitabine in pancreatic cancer cells. DOI 10.1111/j.1742-4658.2012.08521.x ↗
- Paper Transactivation of the human NME5 gene by Sp1 in pancreatic cancer cells. DOI 10.1016/j.gene.2012.04.088 ↗
Ming-hua Zhu · 1 shared paper, 2012 · strength 0.03
- Paper Identification of NME5 as a contributor to innate resistance to gemcitabine in pancreatic cancer cells. DOI 10.1111/j.1742-4658.2012.08521.x ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.